Review



human kyse150 cells  (DSMZ)


Bioz Verified Symbol DSMZ is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    DSMZ human kyse150 cells
    KRT15 is enriched in ESCC tumor spheroids and positively correlates with the stemness marker CD44 (A) Stem cell enrichment experiments performed in four cell lines, with images captured over time. (B and C) qPCR analysis of CD44 and KRT15 mRNA expression in tumorspheres versus adherent cells from ECA109, KYSE180, <t>KYSE150,</t> and TE1 cell lines. n = 3, statistical analysis performed using an unpaired t test. Data are represented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (D) Western blot analysis of CD44 and KRT15 protein expression in tumor spheres compared to adherent cells in ECA109 and KYSE180 cell lines.
    Human Kyse150 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 94 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kyse150/KYSE-150/pmc13018899-84-0-4
    Average 95 stars, based on 94 article reviews
    human kyse150 cells - by Bioz Stars, 2026-09
    95/100 stars

    Images

    1) Product Images from "KRT15 identified by scRNA-Seq and machine learning as stemness regulator and prognostic biomarker in ESCC"

    Article Title: KRT15 identified by scRNA-Seq and machine learning as stemness regulator and prognostic biomarker in ESCC

    Journal: iScience

    doi: 10.1016/j.isci.2026.115020

    KRT15 is enriched in ESCC tumor spheroids and positively correlates with the stemness marker CD44 (A) Stem cell enrichment experiments performed in four cell lines, with images captured over time. (B and C) qPCR analysis of CD44 and KRT15 mRNA expression in tumorspheres versus adherent cells from ECA109, KYSE180, KYSE150, and TE1 cell lines. n = 3, statistical analysis performed using an unpaired t test. Data are represented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (D) Western blot analysis of CD44 and KRT15 protein expression in tumor spheres compared to adherent cells in ECA109 and KYSE180 cell lines.
    Figure Legend Snippet: KRT15 is enriched in ESCC tumor spheroids and positively correlates with the stemness marker CD44 (A) Stem cell enrichment experiments performed in four cell lines, with images captured over time. (B and C) qPCR analysis of CD44 and KRT15 mRNA expression in tumorspheres versus adherent cells from ECA109, KYSE180, KYSE150, and TE1 cell lines. n = 3, statistical analysis performed using an unpaired t test. Data are represented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (D) Western blot analysis of CD44 and KRT15 protein expression in tumor spheres compared to adherent cells in ECA109 and KYSE180 cell lines.

    Techniques Used: Marker, Expressing, Western Blot

    Related Articles

    Cell Culture:

    Article Title: Rapid Identification of Esophageal Squamous Cell Carcinoma Biomarkers by MALDI-TOF MS Fingerprinting of Extracellular Vesicles.
    Article Snippet: Get e-Alerts ARTICLE | May 6, 2025 Rapid Identi cation of Esophageal Squamous Cell Carcinoma Biomarkers by MALDI-TOF MS Fingerprinting of Extracellular Vesicles , , and Analytical Chemistry Cite this: Anal.. Chem.. 2025, 97, 19, 10180–10189 https://doi.org/10.1021/acs.analchem.4c06273 Copyright © 2025 American Chemical Society Request reuse permissions Cite Share Jump to Xiaodan Dai Huiying Huang Fei Liu* Open PDF Supporting Information (5) Article Views 396 Altmetric 4 Citations Learn about these metrics Published May 6, 2025 5/28/25, 10:44 PM Rapid Identification of Esophageal Squamous Cell Carcinoma Biomarkers by MALDI-TOF MS Fingerprinting of Extracellular Vesicles | ... https://pubs.acs.org/doi/10.1021/acs.analchem.4c06273 2/24 Esophageal cancer is a major global health challenge, with high incidence and mortality due to the lack of rapid and sensitive diagnostic tools and speci c biomarkers.

    other:

    Article Title: A Wnt-induced lncRNA-DGCR5 splicing switch drives tumor-promoting inflammation in esophageal squamous cell carcinoma.
    Article Snippet: The human ESCC cell lines KYSE140, KYSE180, KYSE520, KYSE510, KYSE450, KYSE30, KYSE410, KYSE180, and KYSE150 were obtained from Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany), the German Resource Center for Biological Material.64 THP-1 and WI-38 were obtained from ATCC.



    Similar Products

    99
    MedChemExpress kyse150
    Kyse150, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kyse150/MG-132/pm41655531-71-20-15
    Average 99 stars, based on 1 article reviews
    kyse150 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    95
    DSMZ human kyse150 cells
    KRT15 is enriched in ESCC tumor spheroids and positively correlates with the stemness marker CD44 (A) Stem cell enrichment experiments performed in four cell lines, with images captured over time. (B and C) qPCR analysis of CD44 and KRT15 mRNA expression in tumorspheres versus adherent cells from ECA109, KYSE180, <t>KYSE150,</t> and TE1 cell lines. n = 3, statistical analysis performed using an unpaired t test. Data are represented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (D) Western blot analysis of CD44 and KRT15 protein expression in tumor spheres compared to adherent cells in ECA109 and KYSE180 cell lines.
    Human Kyse150 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kyse150/KYSE-150/pmc13018899-84-0-4
    Average 95 stars, based on 1 article reviews
    human kyse150 cells - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    86
    Procell Inc kyse150
    KRT15 is enriched in ESCC tumor spheroids and positively correlates with the stemness marker CD44 (A) Stem cell enrichment experiments performed in four cell lines, with images captured over time. (B and C) qPCR analysis of CD44 and KRT15 mRNA expression in tumorspheres versus adherent cells from ECA109, KYSE180, <t>KYSE150,</t> and TE1 cell lines. n = 3, statistical analysis performed using an unpaired t test. Data are represented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (D) Western blot analysis of CD44 and KRT15 protein expression in tumor spheres compared to adherent cells in ECA109 and KYSE180 cell lines.
    Kyse150, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kyse150/cell+kyse150+line/pm41655531-65-5-21
    Average 86 stars, based on 1 article reviews
    kyse150 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    95
    DSMZ fbs kyse150 dsmz rpmi1640 ham s f12
    KRT15 is enriched in ESCC tumor spheroids and positively correlates with the stemness marker CD44 (A) Stem cell enrichment experiments performed in four cell lines, with images captured over time. (B and C) qPCR analysis of CD44 and KRT15 mRNA expression in tumorspheres versus adherent cells from ECA109, KYSE180, <t>KYSE150,</t> and TE1 cell lines. n = 3, statistical analysis performed using an unpaired t test. Data are represented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (D) Western blot analysis of CD44 and KRT15 protein expression in tumor spheres compared to adherent cells in ECA109 and KYSE180 cell lines.
    Fbs Kyse150 Dsmz Rpmi1640 Ham S F12, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kyse150/KYSE-150/us12486262-445-74-76
    Average 95 stars, based on 1 article reviews
    fbs kyse150 dsmz rpmi1640 ham s f12 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    86
    Procell Inc human esca cell lines kyse150
    High tumor expression of LINC01354 holds diagnostic potential in ESCA. ( A ) A comparative analysis of LINC01354 expression and prognosis revealed that LINC01354 was decreased in ESCA and BRCA and led to poor prognosis in patients. ( B , C ) The high expression of LINC01354 in ESCA was validated in additional two cohorts. ( D ) Paired analysis showed that LINC01354 was down-regulated in 95% of ESCA patients in GSE53622 cohort. ( E ) Further analysis depicted that LINC01354 was decreased in 89.9% of ESCA patients in GSE53624 cohort. ( F , G ) ROC analysis was used to evaluate the diagnostic potential of LINC01354 in the GSE53622 (95% confidence interval: 0.8317 to 0.9544) and GSE53624 (95% confidence interval: 0.8374 to 0.9277) cohorts. ( H ) The expression of LINC01354 in Het-1 A, TE1, KYSE70, <t>KYSE150,</t> and KYSE450 cells was examined by qRT-PCR, ** p < 0.01, *** p < 0.001, independent-samples T test. ( I ) FISH was employed to detect the expression of LINC01354 in ESCA TMA, scale bar = 800 μm.
    Human Esca Cell Lines Kyse150, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kyse150/cell+escc+human+kyse30+lines/pmc12534473-33-0-10
    Average 86 stars, based on 1 article reviews
    human esca cell lines kyse150 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    93
    OriGene full length kdm4c kyse150 kdm4c
    High tumor expression of LINC01354 holds diagnostic potential in ESCA. ( A ) A comparative analysis of LINC01354 expression and prognosis revealed that LINC01354 was decreased in ESCA and BRCA and led to poor prognosis in patients. ( B , C ) The high expression of LINC01354 in ESCA was validated in additional two cohorts. ( D ) Paired analysis showed that LINC01354 was down-regulated in 95% of ESCA patients in GSE53622 cohort. ( E ) Further analysis depicted that LINC01354 was decreased in 89.9% of ESCA patients in GSE53624 cohort. ( F , G ) ROC analysis was used to evaluate the diagnostic potential of LINC01354 in the GSE53622 (95% confidence interval: 0.8317 to 0.9544) and GSE53624 (95% confidence interval: 0.8374 to 0.9277) cohorts. ( H ) The expression of LINC01354 in Het-1 A, TE1, KYSE70, <t>KYSE150,</t> and KYSE450 cells was examined by qRT-PCR, ** p < 0.01, *** p < 0.001, independent-samples T test. ( I ) FISH was employed to detect the expression of LINC01354 in ESCA TMA, scale bar = 800 μm.
    Full Length Kdm4c Kyse150 Kdm4c, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kyse150/KDM4C+(NM_001146694)+Human+Tagged+ORF+Clone/pm28835804__ml7b00220_si_001-230-32-38
    Average 93 stars, based on 1 article reviews
    full length kdm4c kyse150 kdm4c - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    KRT15 is enriched in ESCC tumor spheroids and positively correlates with the stemness marker CD44 (A) Stem cell enrichment experiments performed in four cell lines, with images captured over time. (B and C) qPCR analysis of CD44 and KRT15 mRNA expression in tumorspheres versus adherent cells from ECA109, KYSE180, KYSE150, and TE1 cell lines. n = 3, statistical analysis performed using an unpaired t test. Data are represented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (D) Western blot analysis of CD44 and KRT15 protein expression in tumor spheres compared to adherent cells in ECA109 and KYSE180 cell lines.

    Journal: iScience

    Article Title: KRT15 identified by scRNA-Seq and machine learning as stemness regulator and prognostic biomarker in ESCC

    doi: 10.1016/j.isci.2026.115020

    Figure Lengend Snippet: KRT15 is enriched in ESCC tumor spheroids and positively correlates with the stemness marker CD44 (A) Stem cell enrichment experiments performed in four cell lines, with images captured over time. (B and C) qPCR analysis of CD44 and KRT15 mRNA expression in tumorspheres versus adherent cells from ECA109, KYSE180, KYSE150, and TE1 cell lines. n = 3, statistical analysis performed using an unpaired t test. Data are represented as mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (D) Western blot analysis of CD44 and KRT15 protein expression in tumor spheres compared to adherent cells in ECA109 and KYSE180 cell lines.

    Article Snippet: Human: KYSE150 cells , DSMZ , ACC-375.

    Techniques: Marker, Expressing, Western Blot

    High tumor expression of LINC01354 holds diagnostic potential in ESCA. ( A ) A comparative analysis of LINC01354 expression and prognosis revealed that LINC01354 was decreased in ESCA and BRCA and led to poor prognosis in patients. ( B , C ) The high expression of LINC01354 in ESCA was validated in additional two cohorts. ( D ) Paired analysis showed that LINC01354 was down-regulated in 95% of ESCA patients in GSE53622 cohort. ( E ) Further analysis depicted that LINC01354 was decreased in 89.9% of ESCA patients in GSE53624 cohort. ( F , G ) ROC analysis was used to evaluate the diagnostic potential of LINC01354 in the GSE53622 (95% confidence interval: 0.8317 to 0.9544) and GSE53624 (95% confidence interval: 0.8374 to 0.9277) cohorts. ( H ) The expression of LINC01354 in Het-1 A, TE1, KYSE70, KYSE150, and KYSE450 cells was examined by qRT-PCR, ** p < 0.01, *** p < 0.001, independent-samples T test. ( I ) FISH was employed to detect the expression of LINC01354 in ESCA TMA, scale bar = 800 μm.

    Journal: Scientific Reports

    Article Title: Overexpression of LINC01354 predicts well prognosis and suppresses esophageal cancer progression

    doi: 10.1038/s41598-025-20455-2

    Figure Lengend Snippet: High tumor expression of LINC01354 holds diagnostic potential in ESCA. ( A ) A comparative analysis of LINC01354 expression and prognosis revealed that LINC01354 was decreased in ESCA and BRCA and led to poor prognosis in patients. ( B , C ) The high expression of LINC01354 in ESCA was validated in additional two cohorts. ( D ) Paired analysis showed that LINC01354 was down-regulated in 95% of ESCA patients in GSE53622 cohort. ( E ) Further analysis depicted that LINC01354 was decreased in 89.9% of ESCA patients in GSE53624 cohort. ( F , G ) ROC analysis was used to evaluate the diagnostic potential of LINC01354 in the GSE53622 (95% confidence interval: 0.8317 to 0.9544) and GSE53624 (95% confidence interval: 0.8374 to 0.9277) cohorts. ( H ) The expression of LINC01354 in Het-1 A, TE1, KYSE70, KYSE150, and KYSE450 cells was examined by qRT-PCR, ** p < 0.01, *** p < 0.001, independent-samples T test. ( I ) FISH was employed to detect the expression of LINC01354 in ESCA TMA, scale bar = 800 μm.

    Article Snippet: Human ESCA cell lines KYSE150 and TE1 were purchased from Procell (Wuhan, China).

    Techniques: Expressing, Diagnostic Assay, Quantitative RT-PCR

    LINC01354 is involved in cell-cycle regulation and curbs tumorigenesis in ESCA. ( A , B ) Functional enrichment analysis of LINC01354 associated genes in ESCA revealed the biological function of LINC01354. ( C – E ) The effect of overexpression of LINC01354 on ESCA tumor growth was evaluated in a nude mouse model, ** p < 0.01. ( F , G ) The inhibition of LINC01354 on KYSE150 cell cycle process was validated by flow cytometry analysis, **** p < 0.0001.

    Journal: Scientific Reports

    Article Title: Overexpression of LINC01354 predicts well prognosis and suppresses esophageal cancer progression

    doi: 10.1038/s41598-025-20455-2

    Figure Lengend Snippet: LINC01354 is involved in cell-cycle regulation and curbs tumorigenesis in ESCA. ( A , B ) Functional enrichment analysis of LINC01354 associated genes in ESCA revealed the biological function of LINC01354. ( C – E ) The effect of overexpression of LINC01354 on ESCA tumor growth was evaluated in a nude mouse model, ** p < 0.01. ( F , G ) The inhibition of LINC01354 on KYSE150 cell cycle process was validated by flow cytometry analysis, **** p < 0.0001.

    Article Snippet: Human ESCA cell lines KYSE150 and TE1 were purchased from Procell (Wuhan, China).

    Techniques: Functional Assay, Over Expression, Inhibition, Flow Cytometry